Evaluation of Probiotic Bacillus Subtilis Strain in Patients with IBS.
- Conditions
- Health Condition 1: K588- Other irritable bowel syndrome
- Registration Number
- CTRI/2024/03/064089
- Lead Sponsor
- Vidya Herbs Pvt LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients should fulfill Rome Foundation IBS-Diagnostic Questionnaire i.e [Recurrent abdominal pain (on average, at least 1 day or week in the last 3 months) associated with two or more of the following: (Related to defecation, Associated with a change in frequency of stool, Associated with a change in form of stool)].
2.Patients willing to provide written informed consent and comply to protocol requirements
1.Any patient with weight or appetite loss, iron deficiency anemia, fever or rectal bleeding
2.Known inflammatory bowel disease or celiac disease patients,
3.Immuno-compromised patients
4.Pregnancy or wishing to become pregnant during the study
5.End-stage kidney failure on dialysis, presence of other diseases, including cancer or severe hepatic insufficiency (transaminases greater than 3.5x above normal)
6.The use of other probiotic products or antibiotics over the previous 6 months
7.Participation in other clinical trials
8.The presence of other medical conditions that in the opinion of the investigators could jeopardize compliance with the protocol (e.g., malabsorption syndrome or an inability to take orally administered medications).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method